Password has been reset successfully, go to use the new password! Login Account
mini_fungal_metabolite_natural_product_screening_library
/library/mini_fungal_metabolite_natural_product_screening_library
Mini Fungal Metabolite Natural Product Screening Library
Product No.: L6001

For thousands of years,natural products produced by organisms in nature have been utilized as medicines. As early as the second century B.C., Artemisia caruifolia was used to treat malaria. In the early modern era, advances in microbiology, particularly Alexander Fleming's discovery of penicillin, have ushered in a new era of drug discovery from microorganisms. To this day, fungi remain an important source of drugs for infectious diseases. With the rapid development of genome sequencing technology and the exploration of biosynthetic gene clusters, more novel compounds from fungi have been discovered. Fungi can be isolated from soil, water, air, plants and other organisms. In particular, endophytic fungi produce secondary metabolites similar to those of their hosts. Fungal libraries with a high degree of biodiversity are important for both academic research and industry.

Product No.:L6001

Special Note: Each screening well contains natural products from fungal strain metabolism, which are mixtures. For further study of the monomer, please inquire about service fees.

I. Advantages of Mini Fungal Metabolite Natural Product Screening Library

(1) Diversified Natural Product Structure: Fungi can produce a wide range of secondary metabolites with diverse structures. Each fungal screening plate (96-well) contains 80-88 strains, and each strain contains about 100 metabolized natural product structures, and our Mini Fungal Metabolite Natural Product Screening Library consists of 6 fungal screening plates, covering approximately 5,000-50,000 chemical structure spaces. This library is highly valuable for screening research and offers excellent cost-effectiveness.

(2) Large Number of Strains: currently, there are 11,400 collected samples and a total of 21,087 strains

Sample source Number of samples Number of strains
soil 4950 5034
plant 6450 16053
total 11400 21087

(3) Diverse Geographic Locations for Strain Collection: samples were collected from three major continents around the world, including 56 cities and regions such as Kenya, the United States, Canada, Myanmar, and China.

(4) Diversity of Collection Environments (Extreme Environments): We have also collected samples from different landscapes, including hills, mountains, plateaus, canyons, valleys, and bays.

(5) Biodiversity of the Fungal Library: currently, a total of 4,108 fungal species have been identified.

II. Key Features and Usage

(1) Design Principle: The Fungal Extracts Drug Screening Plate utilizes a high throughput screening technique, where extracts from a variety of strains after fermentation and extraction are placed in parallel on a plate in order to be screened for drug activity under uniform conditions. The fungal extracts are different in each well and contain about 500-1,000 natural small molecules.

(2) Drug Screening Method: The fungal extracts to be tested are separately added to the microwells of the screening plate, and then biological reagents containing target cells or enzymes are added to the wells. Next, the screening plate is incubated so that the fungal extracts interact with the target molecules. By detecting the bioactivity signals (e.g., fluorescence, absorbance, etc.) in each well or using other methods, it can be determined whether the extracts contain components with potential drug activity.

(3) Data Analysis: Screening results usually need to be processed and analyzed by bioinformatics methods to identify fungal extracts with drug activity. For the screened active extracts, further separation, purification and structural identification can be performed to determine the specific active ingredients.

(4) Application Fields: The method can be widely applied in various fields like new drug discovery of antimicrobial agents, antitumor agents, and antiviral agents.

III. The catalog price for the Mini Fungal Metabolite Natural Product Screening Library

  • Mini Fungal Metabolite Natural Product Screening Library
Volume Concentration (10mg/mL) Number of Strains Catalog Price/$
30 uL 10 528 3,300
50 uL 10 528 4,620
100 uL 10 528 9,240
200 uL 10 528 15,870

IV. Service Fee for monomer extraction

(1) Crude Extract Pricing

Specification Catalog Price/ $ Extractable monomer quantity Remarks
1g 500 About 1mg The quantity of the standard reference material
20g 3,750 About 2mg The quantity for analysis or testing
100g 7,500 About 10mg The finished product

(2) Service Fee for monomer extraction

The pricing for this section is determined based on customer requirements, and a quote will be provided once the specific demands are clarified.

Compound Service
Our compound library can be flexibly customized!View More
Compound library Consultation
Composition of compound library
Example of compound library information
Empty 1000025-07-9 1000413-72-8 229005-80-5 1000787-75-6 946387-07-1 1000998-59-3 1175526-27-8 1001288-58-9 1001350-96-4 1001404-83-6 Empty
Vadadustat TAK875 TAK-779 Tegobuvir RN-1734 BMS-687453 AM211 FT011 BMS754807 AAI101
Empty 1001625-82-6 1001645-58-4 1001753-24-7 1001908-89-9 1002304-34-8 1002-84-2 100291-86-9 100299-08-9 10030-52-1 10040-45-6 Empty
RPW-24 SRT1720 hydrochloride INH6 SRT 2183 AMG208 Pentadecanoic acid Apiopaeonoside Pemirolast potassium L-Anserine nitrate salt Sodium Picosulfate
Empty 100427-26-7 1004316-88-4 10045-45-1 100462-37-1 1004990-28-6 100-51-6 1005-24-9 1005264-47-0 1005334-57-5 1005342-46-0 Empty
Lercanidipine Cobicistat 1-Ethyl-2-benzimidazolinone ROSIRIDIN PF-AKT400 Benzyl alcohol 1-Methylnicotinamide chloride MX69 CVT-10216 LCL161
Empty 1005491-05-3 100-55-0 1005504-62-0 1005883-72-6 100643-71-8 1007207-67-1 10075-50-0 1007647-73-5 100784-20-1 10083-24-6 Empty
Tirasemtiv Roniacol Rg3039 Z433927330 Desloratadine CH5132799 5-Bromoindole Smurf1-IN-A01 Halosulfuron-methyl Piceatannol
Empty 100872-83-1 100874-08-6 1009119-64-5 1009119-65-6 100929-71-3 1009298-09-2 1009298-59-2 100929-99-5 1009734-33-1 10097-84-4 Empty
ML346 SB 4 Daclatasvir Daclatasvir dihydrochloride NADPH (tetracyclohexanamine) AZD8055 Vistusertib PAβN dihydrochloride HZ1157 Rotundine
Empty 1009816-48-1 1009817-63-3 1009820-21-6 100986-85-4 101001-34-7 1010411-21-8 1010-60-2 1011244-68-0 1011301-27-1 1011529-10-4 Empty
Thiamet G B-AP15 Silmitasertib Levofloxacin Pamicogrel GSK369796 Dihydrochloride 2-Chloronaphthoquinone TFAP Tenovin3 Azvudine
Empty 101152-94-7 101155-02-6 1011557-82-6 1011-74-1 101-20-2 1012054-59-9 101-21-3 101-26-8 101303-98-4 1013101-36-4 Empty
Milnacipran hydrochloride BW-A78U Tenovin-6 DL-Normetanephrine hydrochloride Triclocarban CUDC101 Chlorpropham Mestinon Zacopride hydrochloride PF04691502
Empty 101-31-5 1013-69-0 1013750-77-0 1013753-99-5 10138-52-0 1013920-15-4 1013937-63-7 1014691-61-2 101477-54-7 101494-95-5 Empty
L-Hyoscyamine Noreugenin ML-030 BC-1382 Gadolinium chloride Vorolanib VTP-27999 TFA GSK0660 Lomerizine hydrochloride 8-CHLOROQUINAZOLIN-4(1H)-ONE